Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

776
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
776
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

844
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
844
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

619
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
619
Truncation in Survival Analysis01:09

Truncation in Survival Analysis

643
Truncation in survival analysis refers to the exclusion of individuals or events from the dataset based on specific criteria related to the time of the event. This exclusion can happen in two primary forms: left truncation and right truncation.
Left truncation occurs when individuals who experienced the event of interest before a certain time are not included in the study. This is often due to a "delayed entry" into the study where only those who survive until a certain entry point are...
643
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

437
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
437
Parametric Survival Analysis: Weibull and Exponential Methods01:14

Parametric Survival Analysis: Weibull and Exponential Methods

1.1K
Parametric survival analysis models survival data by assuming a specific probability distribution for the time until an event occurs. The Weibull and exponential distributions are two of the most commonly used methods in this context, due to their versatility and relatively straightforward application.
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Metaplastic carcinoma of the breast and the impact of the p63 and cytokeratin 5/6: experience of 40 patients].

Ginecologia y obstetricia de Mexico·2016
Same author

Multifactorial analysis of survival and recurrences in differentiated thyroid cancer. Comparative evaluation of usefulness of AGES, MACIS, and risk group scores in Mexican population.

Journal of experimental & clinical cancer research : CR·2002
Same author

Electrochemotherapy in primary and metastatic skin tumors: phase II trial using intralesional bleomycin.

Archives of medical research·2001
Same author

Breast carcinoma presents a decade earlier in Mexican women than in women in the United States or European countries.

Cancer·2001
Same author

[Breast cancer in Mexico. Is it a young women disease?].

Ginecologia y obstetricia de Mexico·2000
Same author

[Use of a questionnaire for screening people with undiagnosed diabetes].

Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion·1999

Related Experiment Video

Updated: Feb 14, 2026

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

9.6K

[Breast Cancer Survival: Clinical andPathological Prognostic Factors Analysis].

A Maffuz-Aziz, S Labastida-Almendaro, S Sherwell-Cabello

    Ginecologia Y Obstetricia De Mexico
    |February 10, 2018
    PubMed
    Summary

    This study analyzed 4,902 breast cancer patients in Mexico, finding that early detection through mammography screening significantly improves overall survival (OS) and disease-free survival (DFS). Understanding prognostic factors is crucial for personalized breast cancer treatment and better patient outcomes.

    More Related Videos

    Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis
    06:03

    Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis

    Published on: February 6, 2020

    7.2K
    Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
    05:16

    Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

    Published on: June 10, 2025

    666

    Related Experiment Videos

    Last Updated: Feb 14, 2026

    Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
    07:41

    Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

    Published on: May 17, 2019

    9.6K
    Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis
    06:03

    Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis

    Published on: February 6, 2020

    7.2K
    Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
    05:16

    Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

    Published on: June 10, 2025

    666

    Area of Science:

    • Oncology
    • Public Health
    • Epidemiology

    Background:

    • Breast cancer is a leading cause of cancer mortality in Mexican women.
    • The disease's heterogeneity necessitates understanding prognostic factors for effective treatment decisions.

    Purpose of the Study:

    • To determine the 5-year overall survival (OS) and disease-free survival (DFS) rates in breast cancer patients.
    • To analyze survival outcomes based on different risk groups and clinical factors.

    Main Methods:

    • A retrospective analysis of 4,902 breast cancer patients treated at FUCAM from July 2005 to December 2014.
    • Kaplan-Meier curves were used to analyze 5-year OS and DFS.
    • Subset analyses included clinical stage and comparison between screening-detected and symptomatic patients.

    Main Results:

    • Patients diagnosed via mammography screening had significantly better OS (95%) and DFS (93%) compared to symptomatic patients (79% OS, 77% DFS).
    • Survival rates varied by stage: early (96.8% OS, 93.4% DFS), locally advanced (74.6% OS, 68.7% DFS), and metastatic (35.9% OS, 37.4% DFS).
    • Triple-negative breast cancer showed the lowest survival rates (69% OS, 73% DFS).

    Conclusions:

    • Identifying prognostic factors is essential for risk stratification and personalized breast cancer treatment.
    • Early detection strategies, such as mammography screening, are vital for improving survival outcomes in breast cancer patients.
    • Individualized treatment approaches based on risk groups can enhance life expectancy for women with breast cancer.